Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. | Vaccine;19(15-16): 2071-9, 2001 Feb 28. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.

Hagiwar, Y; Tsuji, T; Iwasaki, T; Kadowaki, S; Asanuma, H; Chen, Z; Komase, K; Suzuki, Y; Aizawa, C; Kurata, T; Tamura, S.

Affiliation

Hagiwar Y; Department of Pathology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, 162-8640, Tokyo, Japan.

Vaccine ; 19(15-16): 2071-9, 2001 Feb 28.

Article in En | MEDLINE | ID: mdl-11228379

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Influenza Vaccines / Adjuvants, Immunologic / Escherichia coli Proteins / Enterotoxins / Escherichia coli Limits: Animals Language: En Journal: Vaccine Year: 2001 Document type: Article Affiliation country: Japón Country of publication: Países Bajos

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Influenza Vaccines / Adjuvants, Immunologic / Escherichia coli Proteins / Enterotoxins / Escherichia coli Limits: Animals Language: En Journal: Vaccine Year: 2001 Document type: Article Affiliation country: Japón Country of publication: Países Bajos